| 1 |
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD  |
미소장 |
| 2 |
Hippocampal volume and depression: a meta-analysis of MRI studies.  |
미소장 |
| 3 |
Gene expression in major depressive disorder.  |
미소장 |
| 4 |
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression  |
미소장 |
| 5 |
Relationship between blood pressure and depression in the elderly. The Three-City Study  |
미소장 |
| 6 |
Dentate gyrus volume and memory performance in major depressive disorder  |
미소장 |
| 7 |
TM. Fonseka et al., "Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder," Journal of Affective Disorders, Vol. 233, pp. 21-35, 2018. |
미소장 |
| 8 |
DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations  |
미소장 |
| 9 |
Development and evaluation of a multimodal marker of major depressive disorder  |
미소장 |
| 10 |
J Yang et al., "Depression detection via Harvesting Social Media: A Multimodal Dictionary Learning Solution," Proc. of the Twenty-Sixth International Joint Conference on Artificial Intelligence 2017, pp. 3838-3844, 2017. |
미소장 |
| 11 |
GeneCards: integrating information about genes, proteins and diseases  |
미소장 |
| 12 |
The association between substance P and white matter integrity in medication-naive patients with major depressive disorder  |
미소장 |
| 13 |
Genetic and epigenetic associations ofMAOAandNR3C1with depression and childhood adversities  |
미소장 |